Journal of Antimicrobial Chemotherapy (2001) 48, 383-389
© 2001 The British Society for Antimicrobial Chemotherapy
CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999–December 2000)
a Microbiology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma 08025 Barcelona; b Microbiology Department, Complejo Hospitalario Donostia, Universidad del País Vasco, Avenida Dr. Beguiristain s/n, 20014 San Sebastián, Spain
CMY-2 plasmid-mediated AmpC ß-lactamase (CMY-2) was detected in 21 isolates from two hospitals located in different geographical regions of Spain between October 1999 and December 2000. The isolates comprised two Salmonella enterica serovars (Mikawasima and Montevideo), 16 Escherichia coli, one Klebsiella pneumoniae, one Klebsiella oxytoca and one Proteus mirabilis. In addition to the expected resistance to ß-lactams, including extended-spectrum cephalosporins and cefoxitin, all isolates showed a broad spectrum of associated resistance. All were resistant to sulfamethoxazole, chloramphenicol, tetracycline and streptomycin, and all but two were also resistant to gentamicin. Five isolates were studied in detail and all transferred CMY-2 and other resistance determinants by conjugation. Genomic DNA restriction pattern analysis of the E. coli isolates excluded the dissemination of a single clone. To the best of our knowledge this is the first time that CMY-2 has been detected in P. mirabilis, K. oxytoca and S. enterica serovars Mikawasima and Montevideo. It is also the first time that CMY-2 has been described in Spain.
* Corresponding author. Tel: +34-943-00-70-46; Fax: +34-943-00-70-63; E-mail: labmikro{at}terra.es
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. F. Mataseje, J. Xiao, S. Kost, L.-K. Ng, K. Dore, M. R. Mulvey, and on behalf of the Canadian Public Health Laboratory Characterization of Canadian cefoxitin-resistant non-typhoidal Salmonella isolates, 2005-06 J. Antimicrob. Chemother., October 1, 2009; 64(4): 723 - 730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lavilla, J. J. Gonzalez-Lopez, E. Miro, A. Dominguez, M. Llagostera, R. M. Bartolome, B. Mirelis, F. Navarro, and G. Prats Dissemination of extended-spectrum {beta}-lactamase-producing bacteria: the food-borne outbreak lesson J. Antimicrob. Chemother., June 1, 2008; 61(6): 1244 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Aragon, B. Mirelis, E. Miro, C. Mata, L. Gomez, A. Rivera, P. Coll, and F. Navarro Increase in {beta}-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type {beta}-lactamases J. Antimicrob. Chemother., May 1, 2008; 61(5): 1029 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li, Q. Li, Y. Du, X. Jiang, J. Tang, J. Wang, G. Li, and Y. Jiang Prevalence of Plasmid-Mediated AmpC {beta}-Lactamases in a Chinese University Hospital from 2003 to 2005: First Report of CMY-2-Type AmpC {beta}-Lactamase Resistance in China J. Clin. Microbiol., April 1, 2008; 46(4): 1317 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. Sidjabat, K. M. Townsend, M. Lorentzen, K. S. Gobius, N. Fegan, J. J.-C. Chin, K. A. Bettelheim, N. D. Hanson, J. C. Bensink, and D. J. Trott Emergence and spread of two distinct clonal groups of multidrug-resistant Escherichia coli in a veterinary teaching hospital in Australia. J. Med. Microbiol., August 1, 2006; 55(Pt 8): 1125 - 1134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. D'Andrea, E. Nucleo, F. Luzzaro, T. Giani, R. Migliavacca, F. Vailati, V. Kroumova, L. Pagani, and G. M. Rossolini CMY-16, a Novel Acquired AmpC-Type {beta}-Lactamase of the CMY/LAT Lineage in Multifocal Monophyletic Isolates of Proteus mirabilis from Northern Italy Antimicrob. Agents Chemother., February 1, 2006; 50(2): 618 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Batchelor, K. L. Hopkins, E. J. Threlfall, F. A. Clifton-Hadley, A. D. Stallwood, R. H. Davies, and E. Liebana Characterization of AmpC-Mediated Resistance in Clinical Salmonella Isolates Recovered from Humans during the Period 1992 to 2003 in England and Wales J. Clin. Microbiol., May 1, 2005; 43(5): 2261 - 2265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Miro, B. Mirelis, F. Navarro, L. Matas, M. Gimenez, and C. Rabaza Escherichia coli Producing an ACC-1 Class C {beta}-Lactamase Isolated in Barcelona, Spain Antimicrob. Agents Chemother., February 1, 2005; 49(2): 866 - 867. [Full Text] [PDF]
|
|
|
|
|
|
T. Kruger, D. Szabo, K. H. Keddy, K. Deeley, J. W. Marsh, A. M. Hujer, R. A. Bonomo, and D. L. Paterson Infections with Nontyphoidal Salmonella Species Producing TEM-63 or a Novel TEM Enzyme, TEM-131, in South Africa Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4263 - 4270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Edelstein, M. Pimkin, T. Dmitrachenko, V. Semenov, N. Kozlova, D. Gladin, A. Baraniak, and L. Stratchounski Multiple Outbreaks of Nosocomial Salmonellosis in Russia and Belarus Caused by a Single Clone of Salmonella enterica Serovar Typhimurium Producing an Extended-Spectrum {beta}-Lactamase Antimicrob. Agents Chemother., August 1, 2004; 48(8): 2808 - 2815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Makanera, G. Arlet, V. Gautier, and M. Manai Molecular Epidemiology and Characterization of Plasmid-Encoded {beta}-Lactamases Produced by Tunisian Clinical Isolates of Salmonella enterica Serotype Mbandaka Resistant to Broad-Spectrum Cephalosporins J. Clin. Microbiol., July 1, 2003; 41(7): 2940 - 2945. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Armand-Lefevre, V. Leflon-Guibout, J. Bredin, F. Barguellil, A. Amor, J. M. Pages, and M.-H. Nicolas-Chanoine Imipenem Resistance in Salmonella enterica Serovar Wien Related to Porin Loss and CMY-4 {beta}-Lactamase Production Antimicrob. Agents Chemother., March 1, 2003; 47(3): 1165 - 1168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Miro, F. Navarro, B. Mirelis, M. Sabate, A. Rivera, P. Coll, and G. Prats Prevalence of Clinical Isolates of Escherichia coli Producing Inhibitor-Resistant {beta}-Lactamases at a University Hospital in Barcelona, Spain, over a 3-Year Period Antimicrob. Agents Chemother., December 1, 2002; 46(12): 3991 - 3994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sanchez, M. A. McCrackin Stevenson, C. R. Hudson, M. Maier, T. Buffington, Q. Dam, and J. J. Maurer Characterization of Multidrug-Resistant Escherichia coli Isolates Associated with Nosocomial Infections in Dogs J. Clin. Microbiol., October 1, 2002; 40(10): 3586 - 3595. [Abstract] [Full Text] [PDF]
|
|